Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions

Macular HolesRetinal Detachment

Interventions

BIOLOGICAL

Visio-AMTRIX

Chemically-treated, viro-inactivated, freeze-dried and irradiated amniotic membrane placed by the investigator during macular hole surgery

Trial Locations (1)

Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon